FOXO4-DRI is a novel peptide derived from the forkhead box O (FOXO) transcription factor, which plays a critical role in regulating cellular stress responses, apoptosis, and longevity
Clinical Trial Safety Data: Across multiple studies using oral and intravenous AOD-9604 for up to 24 weeks, the peptide demonstrated an excellent safety profile indistinguishable from placebo
Brubaker says drugs need to be carefully tested in stages before they are approved for use in people
Ways to Watch & Listen Discover Financial Issues live each weekday or on-demandavailable on web, mobile app, Roku, Fire TV, social media, and radio
It is one of the most broadly researched peptides for accelerated recovery across multiple tissue types
FarrRVanheelHVanuytselTMasaokaTTrnblomHSimrnMet al